Amsterdam institute for Immunology and Infectious diseases
AI&I news
Amsterdam UMC and Reade Launch the Spondyloarthritis Center AmsterdamSince this spring, rheumatologists from Amsterdam UMC and Reade have teamed up to form the Spondyloarthritis Center Amsterdam, aiming to raise the standard of care for patients with spondyloarthritis, a chronic inflammatory condition affecting joints and the spine, often linked to other autoimmune diseases such as psoriasis, Crohn’s disease, or eye inflammation.
€14.6 Million for CAR-T Cell Therapy Research in Autoimmune DiseasesAmsterdam UMC and Leiden University Medical Center (LUMC) are launching a six-year clinical study to investigate the efficacy, safety, affordability, and accessibility of CAR-T cell therapy for severe autoimmune diseases. The Dutch National Health Care Institute and ZonMw are funding the study with €14.6 million.
Reprogramming Immunity: A Cheaper, Faster Future for CAR-T Therapy?A groundbreaking shift in cancer immunotherapy may be on the horizon. While CAR-T cell therapy has proven remarkably effective in treating certain blood cancers, its complex and costly manufacturing process has limited widespread use. Now, a new approach developed by researchers at the University of Pennsylvania and Capstan Therapeutics could simplify treatment, by training the immune system inside the body. Dutch hematologist Prof. Marie José Kersten weighs in on the promise, challenges, and potential impact of this living therapy’s next evolution.
